Hepatic origin of increased serum TFF3 in gastric cancer bearing subjects - Quiz - MDSpire

Elevated Serum TFF3 Levels in Patients with Gastric Cancer: A Hepatic Source Investigation

  • By

  • Komei Kuge

  • Junko Mukoyama

  • Yoshimi Yasukawa

  • Yuko Ishibashi

  • Hiroki Masuda

  • Tomohiko Yasuda

  • Yasukazu Ohmoto

  • Hideyuki Takeshima

  • Akihisa Matsuda

  • Hiroshi Yoshida

  • Yasuyuki Seto

  • James R. Goldenring

  • Toshikazu Ushijima

  • Sachiyo Nomura

  • July 20, 2026

Share

Original Source(s)

Hepatic origin of increased serum TFF3 in gastric cancer bearing subjects

  • by Komei Kuge, Junko Mukoyama, Yoshimi Yasukawa, Yuko Ishibashi, Hiroki Masuda, Tomohiko Yasuda, Yasukazu Ohmoto, Hideyuki Takeshima, Akihisa Matsuda, Hiroshi Yoshida, Yasuyuki Seto, James R. Goldenring, Toshikazu Ushijima, Sachiyo Nomura

  • July 20, 2026

Related Content

The Secrets of the Gut

Going beyond the gut: why microbiome testing is the next big thing in drug development

An FDG-first functional imaging approach in phaeochromocytoma and paraganglioma

Clinical characteristics of pediatric tumor-induced osteomalacia: a systematic review and individual patient data analysis